EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Signature Construction Associated with Tumor-Infiltrating Macrophages Identifies IRF8 as a Novel Biomarker for Immunotherapy in Advanced Gastric Cancer

Wanqian Liao iD, Yu Wang, Rui Wang, Bibo Fu, Xiangfu Chen, Ying Ouyang, Bing Bai, Ying Jin iD, Yunxin Lu, Furong Liu, Yang Zhang, Dongni Shi und 1 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26031089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Wanqian Liao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen Uni…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Interferon Regulatory Factors, Tumor-Associated Macrophages, Immunotherapy. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced gastric cancer (AGC) is characterized by poor prognosis and limited responsiveness to immunotherapy. Tumor-associated macrophages (TAMs) play a pivotal role in cancer progression and therapeutic outcomes. In this study, we developed a novel gene signature associated with M1-like TAMs using data from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) to predict prognosis and immunotherapy response. This gene signature was determined as an independent prognostic indicator for AGC, with high-risk patients exhibiting an immunosuppressive tumor immune microenvironment (TIME) and poorer survival outcomes. Furthermore, Interferon regulatory factor 8 (IRF8) was identified as a key gene and validated through in vitro and in vivo experiments. IRF8 overexpression reshaped the suppressive TIME, leading to an increased presence of M1-like TAMs, IFN-γ+ CD8+ T cells, and Granzyme B+ CD8+ T cells. Notably, the combination of IRF8 overexpression and anti-PD-1 therapy significantly inhibited tumor growth in syngeneic mouse models. AGC patients with elevated IRF8 expression were found to be more responsive to anti-PD-1 treatment. These findings highlight potential biomarkers for prognostic evaluation and immunotherapy in AGC, offering insights that could guide personalized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsInterferon Regulatory FactorsTumor-Associated MacrophagesImmunotherapyBiomarkers, TumorHumansAnimalsMiceTumor MicroenvironmentPrognosisGene Expression Regulation, NeoplasticCell Line, TumorFemaleMaleCD8-Positive T-LymphocytesInterferon Regulatory Factor-8

Stichwörter der Autor:innen

AGCIRF8TAMsimmunotherapy predictionprognostic signature

Substanzen

Interferon Regulatory FactorsBiomarkers, TumorInterferon Regulatory Factor-8

Autor:innen und Institutionen

  • Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Integrated Traditional Chinese and Western Medicine Research Center, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

ORCID-Profile: Wanqian Liao, Ying Jin, Dongsheng Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liao, W., Wang, Y., Wang, R., Fu, B., Chen, X., Ouyang, Y., Bai, B., Jin, Y., Lu, Y., Liu, F., Zhang, Y., Shi, D., & Zhang, D. (2025). Signature Construction Associated with Tumor-Infiltrating Macrophages Identifies IRF8 as a Novel Biomarker for Immunotherapy in Advanced Gastric Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031089

Vancouver

Liao W, Wang Y, Wang R, Fu B, Chen X, Ouyang Y, et al. Signature Construction Associated with Tumor-Infiltrating Macrophages Identifies IRF8 as a Novel Biomarker for Immunotherapy in Advanced Gastric Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031089

BibTeX
@article{Liao2025,
  author = {Liao, Wanqian and Wang, Yu and Wang, Rui and Fu, Bibo and Chen, Xiangfu and Ouyang, Ying and Bai, Bing and Jin, Ying and Lu, Yunxin and Liu, Furong and Zhang, Yang and Shi, Dongni and Zhang, Dongsheng},
  title = {Signature Construction Associated with Tumor-Infiltrating Macrophages Identifies IRF8 as a Novel Biomarker for Immunotherapy in Advanced Gastric Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26031089}
}
Kostenlos starten →